Background—Phase I clinical studies have demonstrated the feasibility of implanting
autologous skeletal myoblasts in postinfarction scars. However, they have failed to …

Cell transplantation is emerging as a new treatment designed to improve the poor outcome
of patients with cardiac failure. Its rationale is that implantation of contractile cells into …

Background—Successful autologous skeletal myoblast transplantation into infarcted
myocardium in a variety of animal models has demonstrated improvement in cardiac …

Successful autologous skeletal myoblast transplantation into infarcted myocardium in a
variety of animal models has demonstrated improvement in cardiac function. We evaluated …

Objectives: This phase I trial was designed to assess the feasibility and safety of autologous
skeletal myoblast transplantation in patients with severe ischemic cardiomyopathy …

OBJECTIVE: To determine the feasibility and safety of skeletal myoblast transplantation in
patients with chronic myocardial infarction undergoing coronary artery bypass grafting …

Objectives: We report on the procedural and six-month results of the first percutaneous and
stand-alone study on myocardial repair with autologous skeletal myoblasts. Background …

After a decade of experimental work, skeletal myoblast transplantation has now entered the
clinical arena as a potentially new means of improving the function of the failing heart …

BACKGROUND: We sought to determine the safety and preliminary efficacy of transcatheter
intramyocardial administration of myoblasts in patients with heart failure (HF). METHODS …

Background—Skeletal myoblast (SM) transplantation (Tx) in a post-myocardial infarction
(MI) scar experimentally improves left ventricular (LV) ejection fraction (EF). Short-term …